Last $346.92 USD
Change Today -3.09 / -0.88%
Volume 401.8K
REGN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Munich
As of 5:20 PM 08/28/14 All times are local (Market data is delayed by at least 15 minutes).

BOARD MEMBERS AFFILIATED WITH Peter Powchik M.D.*

Senior Vice President of Clinical Development
9
9
AgeTotal Annual Compensation
56--
 
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
REGN:US $346.92 USD -3.09

MOST CONNECTED PEOPLE TO Peter Powchik M.D.

NameRelationships
Jonathan J. Fleming 134 Relationships
Paul D. Goldenheim 107 Relationships
Edward M. Scolnick 85 Relationships
Joel F. Martin 48 Relationships
Thomas Roth 48 Relationships

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REGENERON PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.